Sanofi launches digital knowledge platform sanoficampus.in : Here's everything we know so far!
Mumbai: In an effort to provide practicing Indian Doctors with trusted and relevant medical content, Global pharmaceutical company Sanofi has now launched its knowledge platform- sanoficampus.in in India.
The digital platform offers educational content, training, disease information, product information, news, and other relevant information to all health care professionals (HCPs) in India. Currently, relevant medical content for Diabetes, Thrombosis, Gut Health, Respiratory Diseases, Otolaryngeal Disorders, CNS (Central Nervous System), Kidney Transplant, and Pediatric Disorders is available on the platform, content for additional specializations such as Rare Diseases will be added soon.
In addition, the platform also provides meaningful updates for doctors to improve their practice, regardless of their specialization, including topics such as telemedicine, physicians' health, and much more.
The platform also offers resources and materials to help improve patients' daily lives, the company's product portfolio, and its active pharmaceutical ingredients (API) information. Additionally, the platform allows the visitor to browse through a wide variety of -
- Articles
- Videos by national and international speakers
- Podcasts
- Tools, conferences, and scientific events in different therapeutic areas and many more.
The move is a part of the global digital initiative to empower healthcare practitioners in clinical decision-making and to enable them to serve patients better. Sanofi currently offers similar HCP-based digital platforms in multiple regions across the globe.
With the platform, Sanofi intends to make sanoficampus.in the cornerstone of omnichannel customer engagement giving the power in the hands of the HCPs to access trusted and relevant medical information on the go. The website is intended exclusively for registered medical practitioners in India.
Sanofi is an innovative global healthcare company, spreading across some 100 countries, driven by the purpose of chasing the miracles of science to improve people's lives. The company has provided potentially life-changing treatment options and life-saving vaccine protection to millions of people globally. The local entities include Sanofi India Limited (listed on the stock exchange) and Sanofi Healthcare India Pvt. Ltd. (SHIPL), which engage across the entire health spectrum from prevention with vaccines to wellness, treatment, patient support, and capacity building.
For the use of Registered Medical Practitioners only.MAT-IN-2202387-1.0-10/22
Disclaimer: This post has been published under MD Brand Connect Initiative and is sponsored by Sanofi.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.